Modulating fat levels essential for successful pregnancy

September 20, 2007

New data, generated in mice by Richard Proia and colleagues at the National Institutes of Health, Bethesda, provides a potential reason for early pregnancy loss in humans.

Female mice lacking a protein known as sphingosine kinase 1 (Sphk1) and expressing reduced levels of Sphk2 (Sphk1-/-Sphk2+/- mice) were found to be infertile. Although embryos implanted into the womb, the womb failed to respond correctly to this -- the structures that support the developing embryo before a functional placenta is established (the decidua) were defective. In particular, there was increased death of decidual cells and breakage of decidual blood vessels, which led to hemorrhaging and early pregnancy loss. As Sphk1 and Sphk2 are involved in metabolizing a group of fats known as sphingolipids, the authors suggested that disturbances in sphingolipid metabolism might be a cause of early pregnancy loss in humans.
-end-
TITLE: Maternal disturbance in activated sphingolipid metabolism causes pregnancy loss in mice

AUTHOR CONTACT:
Richard L. Proia
National Institutes of Health, Bethesda, Maryland, USA.
Phone: (301) 496-4391; Fax: (301) 496-0839; E-mail: proia@nih.gov.

View the PDF of this article at: https://www.the-jci.org/article.php?id=30674

JCI Journals

Related Sphingolipids Articles from Brightsurf:

Study tracks human milk nutrients in infant microbiome
A new study in mice helps explain why gut microbiomes of breastfed infants can differ greatly from those of formula-fed infants.

Flipping a metabolic switch to slow tumor growth
The enzyme serine palmitoyl-transferase can be used as a metabolically responsive ''switch'' that decreases tumor growth, according to a new study by a team of San Diego scientists, who published their findings Aug.

Altered lipid metabolism following childbirth predicts later diabetes risk
Scientists have found that disruptions to the metabolism of lipids occur after childbirth in women with gestational diabetes who go on to develop type 2 diabetes.

Schizophrenia related to abnormal fatty metabolism in the brain
Researchers at the RIKEN Center for Brian Science (CBS) in Japan have discovered a deficiency in the brains of people with schizophrenia that could lead to the development of new drug therapies.

Inhibition of sphingolipid metabolism and neurodegenerative diseases
Disrupting the production of a class of lipids known as sphingolipids in neurons improved symptoms of neurodegeneration and increased survival in a mouse model.

Gut bacteria could guard against Parkinson's, study finds
A common bacteria that boosts digestive health can slow -- and even reverse -- build-up of a protein associated with Parkinson's, new research suggests.

Could sphingolipids help solve a racial paradox in heart disease?
For white patients, lipid test results showing high HDL cholesterol and low LDL cholesterol and triglycerides would be good news, suggesting a lower risk for heart disease.

Scientists discover gene that could help us grow crops faster
Plant scientists at the universities of Cambridge and Bordeaux have discovered a gene that they hope can be used to widen a nutrient trafficking bottleneck and potentially increase crop yields.

How the enzyme lipoxygenase drives heart failure after heart attacks
Heart failure after a heart attack is a global epidemic leading to heart failure pathology.

Natural 'breakdown' of chemicals predicts lung damage in 9/11 firefighters
Abnormal levels of more than two dozen metabolites -- chemicals produced in the body as it breaks down fats, proteins and carbohydrates -- can reliably predict which Sept.

Read More: Sphingolipids News and Sphingolipids Current Events
Brightsurf.com is a participant in the Amazon Services LLC Associates Program, an affiliate advertising program designed to provide a means for sites to earn advertising fees by advertising and linking to Amazon.com.